Rosen Law Firm Urges Alto Neuroscience, Inc. (NYSE: ANRO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.
The Allegations: Rosen Law Firm is Investigating the Allegations that Alto Neuroscience, Inc. (NYSE: ANRO) Misled Investors Regarding its Business Operations.
According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements regarding Alto's business, operations, and prospects. Specifically, the offering documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) ALTO-100 was less effective in treating major depressive disorder ('MDD') than defendants had led investors to believe; (2) accordingly, ALTO-100's clinical, regulatory, and commercial prospects were overstated; (3) as a result, Alto's business and/or financial prospects were overstated; and (4) as a result, Alto's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
What Now: You may be eligible to participate in the class action against Alto Neuroscience, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by September 19, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
CIBC Raises PT on Eldorado Gold Corporation (EGO) from $23 to $32; National Bank and BofA Maintain ‘Outperform' Rating
Eldorado Gold Corporation (NYSE:EGO) is included in our list of the . A golden nugget illuminated under direct lighting, hinting at the value of precious metals. While there's a mixed overall analyst sentiment on Eldorado Gold Corporation (NYSE:EGO), optimistic earnings expectations are driving confidence. On July 15, 2025, CIBC increased its price target on Eldorado Gold Corporation (NYSE:EGO) from $23 to $32, maintaining an 'Outperform' rating. The next day, National Bank also maintained its 'Outperform' rating; however, the analyst lowered their price target from $29.57 to $27.75. Previously, BofA also decreased its price target to $20.81 on July 7, maintaining an 'Outperform' rating, citing revised Q2 commodity pricing models. On the positive side, Zacks expressed optimism regarding the company's future, amid a consistent upward trend in earnings estimates. Analysts have projected an earnings per share (EPS) of $1.73 per share for FY25, matching last year's EPS. Accordingly, it has given a 'Buy' rating on Eldorado Gold Corporation (NYSE:EGO). Operating in Turkey, Canada, and Greece, Eldorado Gold Corporation (NYSE:EGO) produces gold, lead, and zinc. It is included in our list of the best gold stocks. While we acknowledge the potential of EGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Most Undervalued Cloud Stocks Under $10 According to Hedge Funds and 11 Best Mineral Stocks to Buy According to Hedge Funds. Disclosure: None. Melden Sie sich an, um Ihr Portfolio aufzurufen.
Yahoo
24 minutes ago
- Yahoo
HPE Gets a Vote of Confidence: Deutsche Bank Sees Room to Run After Juniper Deal
Hewlett-Packard Enterprise Company (NYSE:HPE) is one of the . On July 23, Deutsche Bank analyst Matt Niknam raised the firm's price target on the stock to $26 from $21 and kept a 'Buy' rating on the shares. The firm is positive on the stock following the Juniper deal, reflecting on the anticipated benefits. According to Niknam, the stock's current valuation offers a promising risk/reward balance for investors. Hewlett Packard Enterprise Company (NYSE:HPE), an American multinational technology company, provides high-performance computing systems, AI software, and data storage solutions for running complex AI workloads. An investor in a suit representing the company, seated in front of a long table of global leaders discussing the company's investments. While we acknowledge the potential of HPE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
CIBC Raises PT on B2Gold Corp. (BTG); Maintains ‘Neutral' Rating
With strong billionaire interest, B2Gold Corp. (NYSE:BTG) is included in our list of the . A golden nugget illuminated under direct lighting, hinting at the value of precious metals. On July 14, 2025, B2Gold Corp. (NYSE:BTG) released a highly favorable Feasibility Study for its 100%-owned Gramalote gold project in Colombia. The study highlights a medium-scale open-pit mine with an 11-year expected life, projected to deliver 2.3 million ounces of gold at an average recovery rate of 95.7%. The annual production is expected at 227,000 ounces in the first five years with all-in sustaining costs of $985/oz, resulting in attractive economics. The after-tax NPV is projected at $941 million at $2,500/oz gold and up to $1.7 billion with spot prices of $3,300/oz. Thanks to strong government support, the completion of extensive drilling, and already-secured permits, the project's development ramp-up is progressing. Meanwhile, permit modifications are expected to take 12-18 months. Three days later, CIBC raised its price target on B2Gold Corp. (NYSE:BTG) from $3.60 to $4.00, maintaining a 'Neutral' rating. With strong fundamentals and cash flow potential, Gramalote is on its track to reshape BTG's growth trajectory. Operating mines in Mali, the Philippines, and Namibia, B2Gold Corp. (NYSE:BTG) is primarily focused on gold production. It is included in our list of the best gold stocks. While we acknowledge the potential of BTG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None.
